Clearmind Medicine Book Value Per Share Growth & History (CMND)
Clearmind Medicine's book value per share was $7.54 for fiscal 2025.
View full Clearmind Medicine company overviewClearmind Medicine annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-10-31 | $7.54 | $6.82 | +935.49% |
| 2024 | 2024-10-31 | $0.73 | -$0.89 | −55.01% |
| 2023 | 2023-10-31 | $1.62 | $26.76 | — |
| 2022 | 2022-10-31 | -$25.14 | -$109.52 | — |
| 2021 | 2021-10-31 | $84.38 | $71.46 | +553.29% |
| 2020 | 2020-10-31 | $12.92 | — | — |
Clearmind Medicine quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-04-30 | $11.28 | -$168.02 | −93.71% |
| Q1 2026 | 2026-01-31 | $54.93 | $29.50 | +115.99% |
| Q4 2025 | 2025-10-31 | $7.54 | $6.82 | +935.49% |
| Q3 2025 | 2025-07-31 | $79.24 | $78.27 | +8022.73% |
| Q2 2025 | 2025-04-30 | $179.30 | $177.87 | +12455.65% |
| Q1 2025 | 2025-01-31 | $25.43 | — | — |
| Q4 2024 | 2024-10-31 | $0.73 | -$0.89 | −55.01% |
| Q3 2024 | 2024-07-31 | $0.98 | — | — |
| Q2 2024 | 2024-04-30 | $1.43 | -$25.33 | −94.66% |
| Q4 2023 | 2023-10-31 | $1.62 | $26.76 | — |
| Q2 2023 | 2023-04-30 | $26.76 | — | — |
| Q4 2022 | 2022-10-31 | -$25.14 | — | — |
Clearmind Medicine book value per share trends
Over the last five fiscal years, Clearmind Medicine's book value per share decreased from $12.92 to $7.54, a change of -$5.37. The latest reported quarter, Q2 2026, shows $11.28.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Clearmind Medicine source filings ↗